Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 176 results found. Search for [ CDSCO ]

Results 20 to 40 of 176
BusinessToday.In
January 2, 2021
Coronavirus vaccination drive: The task force has added 31 COVID-19 vaccine hubs that will supply vaccines to 29,000 vaccination points


BusinessToday.In
January 1, 2021
Covishield has become the first coronavirus vaccine to receive a regulatory nod in India. Now, Drug Controller General of India (DCGI) will take a final call on rolling out the inoculation


BusinessToday.In
January 1, 2021
CDSCO's expert panel has recommended the Serum Institute of India's Covishield COVID-19 vaccine for emergency use authorisation to DCGI


BusinessToday.In
January 1, 2021
Reports suggest that an expert panel will meet to take up the application for emergency use of the three vaccines


Manoj Sharma
December 31, 2020
Suffering poor financial health, Central government has not given a concrete answer on who will bear the cost of vaccinating Indians - Centre, states, or the people themselves


BusinessToday.In
December 30, 2020
The expert committee on COVID-19 analysed the additional data and information that it had asked from SII and Bharat Biotech earlier this month


BusinessToday.In
December 30, 2020
This development comes hours after the UK government accepted the recommendation from the Medicines and Healthcare Regulatory Agency (MHRA) to authorise Oxford University-AstraZeneca's Covid-19 vaccine, named Covishield, for emergency use


PTI
December 27, 2020
Serum Institute of India (SII) has made a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine. The SII has already manufactured 40 million doses of the vaccine


BusinessToday.In
December 26, 2020
Pune-based SII is to submit an updated safety data of phase 2 and 3 clinical trials in India, immunogenicity data from the clinical trial in the UK and India, as well as the assessment results of the UK Medicines and Healthcare products Regulatory Agency


PTI
December 21, 2020
The report comes even as the government considers applications of at least three firms seeking emergency approval to roll out their vaccines against the coronavirus in India


BusinessToday.In
December 17, 2020
Pfizer's statement has come after several reports have surfaced which indicated that the government wouldn't be procuring the Pfizer-BioNTech vaccine because of its high cost and the extreme cold chain requirement of -70 degree Celsius


BusinessToday.In
December 16, 2020
As of now, the Hyderabad-based manufacturer is in Phase III of its candidate's clinical trials, having over 25,800 volunteers across 18 sites in the country


PTI
December 16, 2020
The applications are being examined on scientific basis, using the frameworks that are scientific, frameworks that are globally aligned and ensuring that the vaccine is safe, NITI Aayog member (health) Dr V K Paul said


BusinessToday.In
December 13, 2020
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) sought additional safety and efficacy data for COVID-19 vaccine candidates of Bharat Biotech after deliberating upon its applications seeking emergency use authorisation for the shots


Nidhi Singal
December 10, 2020
The new itel it2192T Thermo Edition can monitor body temperature; the feature phone is equipped with an in-built temperature sensor that enables consumers to monitor their temperature


Nidhi Singal
December 9, 2020
Be it fresh herbs for cooking, indoor air-purifying plants or just succulents, Pico can be used to grow almost any kind of plant. This compact incubator can be attached to any surface to grow a wide variety of plants


BusinessToday.In
December 9, 2020
\"The fundamental that went into the pricing was that we make sure we make it very quickly available to everyone,\" said Pfizer.


BusinessToday.In
December 9, 2020
Several experts have raised questions about Bharat Biotech applying for emergency usage as Covaxin is still going through an efficacy trial. However, the ICMR has backed Bharat Biotech's move


Nidhi Singal
December 3, 2020
\"Due to the convenience of wearable technology people who used to get their vitals checked once a year are now monitoring their parameters several times a week,\" said Vishal Gondal, Founder & CEO, GOQii


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PAGES 2 OF 9  12345